Victory Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-991,014
| Closed | -$22.9M | – | 2640 |
|
|
2023
Q1 | $22.9M | Sell |
991,014
-172,231
| -15% | -$3.99M | 0.03% | 722 |
|
|
2022
Q4 | $30.5M | Buy |
1,163,245
+136,182
| +13% | +$3.57M | 0.04% | 626 |
|
|
2022
Q3 | $20.2M | Buy |
+1,027,063
| New | +$20.2M | 0.02% | 811 |
|
|
2020
Q2 | – | Sell |
-3,832
| Closed | -$52K | – | 3481 |
|
|
2020
Q1 | $52K | Buy |
+3,832
| New | +$52K | ﹤0.01% | 2752 |
|
|
2019
Q4 | – | Sell |
-1,614
| Closed | -$9K | – | 3464 |
|
|
2019
Q3 | $9K | Buy |
+1,614
| New | +$9K | ﹤0.01% | 3311 |
|
|
2019
Q2 | – | Sell |
-242
| Closed | -$5K | – | 1870 |
|
|
2019
Q1 | $5K | Hold |
242
| – | – | ﹤0.01% | 1770 |
|
|
2018
Q4 | $3K | Hold |
242
| – | – | ﹤0.01% | 1776 |
|
|
2018
Q3 | $9K | Buy |
242
+32
| +15% | +$1.19K | ﹤0.01% | 1781 |
|
|
2018
Q2 | $7K | Hold |
210
| – | – | ﹤0.01% | 1817 |
|
|
2018
Q1 | $10K | Hold |
210
| – | – | ﹤0.01% | 1808 |
|
|
2017
Q4 | $8K | Hold |
210
| – | – | ﹤0.01% | 1806 |
|
|
2017
Q3 | $11K | Hold |
210
| – | – | ﹤0.01% | 1797 |
|
|
2017
Q2 | $12K | Buy |
210
+3
| +1% | +$171 | ﹤0.01% | 1794 |
|
|
2017
Q1 | $11K | Hold |
207
| – | – | ﹤0.01% | 1787 |
|
|
2016
Q4 | $12K | Buy |
207
+12
| +6% | +$696 | ﹤0.01% | 1778 |
|
|
2016
Q3 | $12K | Buy |
195
+13
| +7% | +$800 | ﹤0.01% | 1769 |
|
|
2016
Q2 | $10K | Buy |
182
+36
| +25% | +$1.98K | ﹤0.01% | 1623 |
|
|
2016
Q1 | $9K | Buy |
+146
| New | +$9K | ﹤0.01% | 1652 |
|